Ethanol inhibits activation of NLRP3 and AIM2 inflammasomes in human macrophages--a novel anti-inflammatory action of alcohol

Katariina Nurmi, Juhani Virkanen, Kristiina Rajamäki, Katri Niemi, Petri T Kovanen, Kari K Eklund, Katariina Nurmi, Juhani Virkanen, Kristiina Rajamäki, Katri Niemi, Petri T Kovanen, Kari K Eklund

Abstract

Objective: In the pathogenesis of coronary atherosclerosis, local macrophage-driven inflammation and secretion of proinflammatory cytokines, interleukin-1β (IL-1β) in particular, are recognized as key factors. Moderate alcohol consumption is associated with a reduced risk of coronary artery disease mortality. Here we examined in cultured human macrophages whether ethanol modulates the intracellular processes involved in the secretion of IL-1β.

Results: Ethanol decreased dose-dependently the production of mature IL-1β induced by activators of the NLRP3 inflammasome, i.e. ATP, cholesterol crystals, serum amyloid A and nigericin. Ethanol had no significant effect on the expression of NLRP3 or IL1B mRNA in LPS-primed macrophages. Moreover, secretion of IL-1β was decreased in parallel with reduction of caspase-1 activation, demonstrating that ethanol inhibits inflammasome activation instead of synthesis of pro-IL-1β. Acetaldehyde, a highly reactive metabolite of ethanol, had no effect on the ATP-induced IL-1β secretion. Ethanol also attenuated the secretion of IL-1β triggered by synthetic double-stranded DNA, an activator of the AIM2 inflammasome. Ethanol conferred the inhibitory functions by attenuating the disruption of lysosomal integrity and ensuing leakage of the lysosomal protease cathepsin B and by reducing oligomerization of ASC.

Conclusion: Ethanol-induced inhibition of the NLRP3 inflammasome activation in macrophages may represent a biological pathway underlying the protective effect of moderate alcohol consumption on coronary heart disease.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Ethanol inhibits dose-dependently the secretion…
Figure 1. Ethanol inhibits dose-dependently the secretion of IL-1β and IL-18.
LPS-primed human macrophages were preincubated in the presence of the indicated concentrations of ethanol (EtOH: 2.5‰, 5‰, 10‰, and 20‰ corresponding to 43 mM, 86 mM, 171 mM, and 343 mM, respectively) prior to the activation of the NLRP3 inflammasome with (A) cholesterol crystals (CHC), (B) ATP or (C) nigericin (Nig). For activation with (D) SAA no LPS priming was used. To measure the secretion of IL-18, THP-1 cells were preincubated in the presence of the indicated concentrations of ethanol and activated with (E) SAA or (F) nigericin. Cytokine secretion by human primary macrophages (A,B,D) and THP-1 cells (C,E,F) was analyzed by ELISA. The results are expressed as means ± s.e.m from at least 4 individual experiments.
Figure 2. Ethanol inhibits the secretion of…
Figure 2. Ethanol inhibits the secretion of mature IL-1β and caspase-1, but not the expression of pro-IL-1β.
For the measurement of mRNA expression, LPS-primed human primary macrophages were incubated in the presence of the indicated concentrations of ethanol and (A) IL1B and (B) NLRP3 mRNA expression was determined by quantitative real-time RT-PCR. The data are expressed as fold changes compared to the control cells. The results are means ± s.e.m. from 5 individual experiments. For the Western blot studies LPS-primed human THP-1 cells were preincubated in 10‰ (171 mM) ethanol prior to the activation of the NLRP3 inflammasome with (C,G) nigericin and (D) ATP. For activation with (E,F) SAA no LPS priming was used. In IL-1β Western blots of supernatants (SN) or cell lysates (C–E), the p31 band represents pro-IL-1β and the p17 band mature IL-1β. In caspase-1 blots (F,G), the p45 band represents pro-caspase and the p10 band activated caspase-1. Results shown are representative of 3–4 individual experiments.
Figure 3. Ethanol inhibits lysosomal disruption and…
Figure 3. Ethanol inhibits lysosomal disruption and the secretion of active cathepsin B.
(A) THP-1 cells were preincubated in 10‰ (171 mM) ethanol prior to the activation of the NLRP3 inflammasome with cholesterol crystals. Live cells were stained with acridine orange (AO), which changes color from green to orange/red in the acidic pH of lysosomes, or with fluorescently labeled cathepsin B substrate z-Arg-Arg-cresyl violet (catB), which emits red signal upon cleavage by cathepsin. The cells were imaged using epifluorescence microscopy. The images are representative of 3 experiments. (B) LPS-primed THP-1 cells were preincubated in the presence of indicated concentrations of ethanol prior to activation of the NLRP3 inflammasome with nigericin. Cathepsin B/L activity was determined from cell culture media using a fluorescently labeled substrate Z-Phe-Arg-AMC, and the fluorescence was measured after a 60 min incubation at +37°C. The results are expressed as means of ± s.e.m from 3 individual experiments performed in duplicate.
Figure 4. Potassium efflux and ROS are…
Figure 4. Potassium efflux and ROS are not involved in the ethanol-induced inhibition.
(A) THP-1 cells were first preincubated with or without the ROS scavenger N-acetyl-L-cysteine (NAC), then in the presence of 10‰ (171 mM) ethanol, and the NLRP3 inflammasome was activated with SAA. Secretion of IL-1β into the culture medium was analyzed by ELISA. The results are expressed as the means ± s.e.m. from 4 individual experiments, performed in duplicate. (B) THP-1 cells were preincubated in 10‰ (171 mM) ethanol prior to activation of the NLRP3 inflammasome with nigericin. Intracellular potassium was determined by ICP-MS measurement of cell lysates. The results are expressed as means ± s.e.m. from 3 individual experiments.
Figure 5. Ethanol inhibits release and oligomerization…
Figure 5. Ethanol inhibits release and oligomerization of ASC.
(A) LPS-primed THP-1 cells were preincubated in 10‰ (171 mM) ethanol prior to the activation of the NLRP3 inflammasome with nigericin. ASC (22 kDa) was blotted from the supernatants (SN) and cell lysates. Western blots shown are representative of 4 experiments. (B) The intensities of the ASC bands of the cell culture supernatants were analyzed from 4 individual experiments, and are expressed as fold changes compared to the LPS-primed nigericin-activated cells. The results are expressed as means of ± s.e.m. (C) THP-1 cells were preincubated in 10‰ (171 mM) ethanol prior to the activation of the NLRP3 inflammasome with nigericin. Cells were fixed and analyzed for ASC expression using epifluorescence microscopy. (D) To quantify the extent of speck formation, the number of specks was divided by the number of cells per field and expressed as a percentage. The results are expressed as means ± s.e.m. from 4 individual experiments.
Figure 6. Ethanol inhibits AIM2 inflammasome-induced secretion…
Figure 6. Ethanol inhibits AIM2 inflammasome-induced secretion of IL-1β, but not activation of caspase-8.
(A) For the measurement of AIM2 mRNA expression THP-1 cells were preincubated in the presence of the indicated concentrations of ethanol prior to the activation of the AIM2 inflammasome by transfecting the cells with poly (dA:dT). The results are expressed as fold changes compared to unstimulated cells. The data are expressed as means ± s.e.m. from 4 individual experiments. (B) To study the activation of the AIM2 inflammasome, THP-1 cells were preincubated in the presence of the indicated concentrations of ethanol and thereafter the AIM2 inflammasome was activated by transfecting the cells with poly (dA:dT), and the secretion of IL-1β into the culture medium was determined by ELISA. The results are expressed as means ± s.e.m. from 5 individual experiments. (C) THP-1 cells were preincubated in the presence of 10‰ (171 mM) ethanol prior to the activation of the cells with SAA. The activated caspase-8 (p18) was detected from the supernatants and cell lysates. Beta-actin is shown as a loading control. (D) The intensities of the activated caspase-8 bands of the cell culture supernatants were analyzed from 4 individual experiments, and are expressed as fold changes compared to the activated cells. The results are expressed as means of ± s.e.m.
Figure 7. The effect of ethanol on…
Figure 7. The effect of ethanol on the NLRP3 inflammasome-activating danger signals.
1. Priming (left). Binding of lipopolysaccharide (LPS) or serum amyloid A to a toll-like receptor (TLR) activates the receptor which then initiates the synthesis of NLRP3 (nucleotide-binding domain and leucine-rich repeat containing family, pyrin domain containing 3) and pro-interleukin-1β (pro-IL-1β). 2. Activation (right). The pathways leading to activation of NLRP3 inflammasome by the 4 agents (ATP, nigericin, serum amyloid A, and cholesterol crystals) used in this study are shown. Extracellular ATP binds to the P2X purinergic receptor 7 (P2X7), so inducing potassium efflux and reciprocal lowering of the intracellular potassium concentration. Likewise, nigericin induces K+ efflux through its H+/K+ antiporter function and ensuing lowering of the intracellular potassium concentration. Finally, also cholesterol crystals lower the concentration of intracellular potassium. Both ATP and nigericin also trigger the formation of reactive oxygen species (ROS). Nigericin and serum amyloid A, the latter by activating the P2X7 receptor, induce the release of cathepsin B from intact lysosomes into the cytoplasm (intact lysosomes not shown for clarity). Phagocytosed cholesterol crystals cause lysosomal disruption and the leakage of cathepsin B into the cytoplasm. The cytoplasmic elevation of ROS, lowering of potassium, and the elevation of active cathepsin B, each can activate the NLRP3 inflammasome. The activated NLRP3 inflammasome contains active enzyme caspase-1, which cleaves pro-IL-1β and so converts it into the active secretable form. Ethanol inhibits the activation of the NLRP3 inflammasome, thereby reducing the activation of caspase-1 and the secretion of mature IL-1β at two levels: 1) by inhibiting the release of cathepsin B from both the intact and disrupted lysosomes, and 2) by diminishing the assembly of the NLRP3 inflammasome complexes.

References

    1. O’Keefe JH, Bybee KA, Lavie CJ (2007) Alcohol and cardiovascular health: The razor-sharp double-edged sword. J Am Coll Cardiol 50: 1009–1014.
    1. Borriello A, Cucciolla V, Della Ragione F, Galletti P (2010) Dietary polyphenols: Focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis. Nutr Metab Cardiovasc Dis 20: 618–625.
    1. Cui J, Tosaki A, Cordis GA, Bertelli AA, Bertelli A, et al. (2002) Cardioprotective abilities of white wine. Ann N Y Acad Sci 957: 308–316.
    1. Vazquez-Agell M, Sacanella E, Tobias E, Monagas M, Antunez E, et al. (2007) Inflammatory markers of atherosclerosis are decreased after moderate consumption of cava (sparkling wine) in men with low cardiovascular risk. J Nutr 137: 2279–2284.
    1. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ (1999) Moderate alcohol intake and lower risk of coronary heart disease: Meta-analysis of effects on lipids and haemostatic factors. Bmj 319: 1523–1528.
    1. Hines LM, Stampfer MJ, Ma J, Gaziano JM, Ridker PM, et al. (2001) Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med 344: 549–555.
    1. Rimm EB, Klatsky A, Grobbee D, Stampfer MJ (1996) Review of moderate alcohol consumption and reduced risk of coronary heart disease: Is the effect due to beer, wine, or spirits. Bmj 312: 731–736.
    1. Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, et al. (2007) Prognostic significance of the centers for disease Control/American heart association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 115: 1528–1536.
    1. Raum E, Gebhardt K, Buchner M, Schiltenwolf M, Brenner H (2007) Long-term and short-term alcohol consumption and levels of C-reactive protein. Int J Cardiol 121: 224–226.
    1. Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, et al. (2001) Effect of alcohol consumption on systemic markers of inflammation. Lancet 357: 763–767.
    1. Costanzo S, Di Castelnuovo A, Donati MB, Iacoviello L, de Gaetano G (2010) Alcohol consumption and mortality in patients with cardiovascular disease: A meta-analysis. J Am Coll Cardiol 55: 1339–1347.
    1. Libby P (2002) Inflammation in atherosclerosis. Nature 420: 868–874.
    1. Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, et al. (1996) Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol 16: 1000–1006.
    1. Kirii H, Niwa T, Yamada Y, Wada H, Saito K, et al. (2003) Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 23: 656–660.
    1. Merhi-Soussi F, Kwak BR, Magne D, Chadjichristos C, Berti M, et al. (2005) Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc Res 66: 583–593.
    1. Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135–145.
    1. Mariathasan S, Weiss DS, Newton K, McBride J, O’Rourke K, et al. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228–232.
    1. Muruve DA, Petrilli V, Zaiss AK, White LR, Clark SA, et al. (2008) The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452: 103–107.
    1. Kanneganti TD, Body-Malapel M, Amer A, Park JH, Whitfield J, et al. (2006) Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem 281: 36560–36568.
    1. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, et al. (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320: 674–677.
    1. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237–241.
    1. Rajamäki K, Lappalainen J, Öörni K, Välimäki E, Matikainen S, et al. (2010) Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: A novel link between cholesterol metabolism and inflammation. PLoS One 5: e11765.
    1. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, et al. (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357–1361.
    1. Gross O, Thomas CJ, Guarda G, Tschopp J (2011) The inflammasome: An integrated view. Immunol Rev 243: 136–151.
    1. Davis BK, Wen H, Ting JP (2011) The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 29: 707–735.
    1. Hornung V, Latz E (2010) Critical functions of priming and lysosomal damage for NLRP3 activation. Eur J Immunol 40: 620–623.
    1. Hoffman HM, Wanderer AA (2010) Inflammasome and IL-1beta-mediated disorders. Curr Allergy Asthma Rep 10: 229–235.
    1. Grant RW, Dixit VD (2013) Mechanisms of disease: Inflammasome activation and the development of type 2 diabetes. Front Immunol 4: 50.
    1. Stienstra R, van Diepen JA, Tack CJ, Zaki MH, van de Veerdonk FL, et al. (2011) Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A 108: 15324–15329.
    1. Nakanishi S, Vikstedt R, Soderlund S, Lee-Rueckert M, Hiukka A, et al. (2009) Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity. J Lipid Res 50: 183–192.
    1. Niemi K, Teirilä L, Lappalainen J, Rajamäki K, Baumann MH, et al. (2011) Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. J Immunol 186: 6119–6128.
    1. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25: 402–408.
    1. Hentze H, Lin XY, Choi MS, Porter AG (2003) Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin. Cell Death Differ 10: 956–968.
    1. Luheshi NM, Giles JA, Lopez-Castejon G, Brough D (2012) Sphingosine regulates the NLRP3-inflammasome and IL-1beta release from macrophages. Eur J Immunol 42: 716–725.
    1. International Organization for Standardization (2003) ISO 17294-2: 2003 Water quality. Application of inductively coupled plasma mass spectrometry (ICP-MS). Part 2: Determination of 62 elements. (Geneve: International Organization for Standardization).
    1. Hutson JL, Wickramasinghe SN (1999) Expression of CYP2E1 by human monocyte-derived macrophages. J Pathol 188: 197–200.
    1. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, et al. (2009) Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183: 787–791.
    1. Fenton MJ, Vermeulen MW, Clark BD, Webb AC, Auron PE (1988) Human pro-IL-1 beta gene expression in monocytic cells is regulated by two distinct pathways. J Immunol 140: 2267–2273.
    1. Van Noorden CJ, Boonacker E, Bissell ER, Meijer AJ, van Marle J, et al. (1997) Ala-pro-cresyl violet, a synthetic fluorogenic substrate for the analysis of kinetic parameters of dipeptidyl peptidase IV (CD26) in individual living rat hepatocytes. Anal Biochem 252: 71–77.
    1. Knight CG (1980) Human cathepsin B. application of the substrate N-benzyloxycarbonyl-L-arginyl-L-arginine 2-naphthylamide to a study of the inhibition by leupeptin. Biochem J 189: 447–453.
    1. Cruz CM, Rinna A, Forman HJ, Ventura AL, Persechini PM, et al. (2007) ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem 282: 2871–2879.
    1. van de Veerdonk FL, Smeekens SP, Joosten LA, Kullberg BJ, Dinarello CA, et al. (2010) Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease. Proc Natl Acad Sci U S A 107: 3030–3033.
    1. Meissner F, Seger RA, Moshous D, Fischer A, Reichenbach J, et al. (2010) Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood 116: 1570–1573.
    1. Meissner F, Molawi K, Zychlinsky A (2008) Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat Immunol 9: 866–872.
    1. Brown SD, Brown LA (2012) Ethanol (EtOH)-induced TGF-beta1 and reactive oxygen species production are necessary for EtOH-induced alveolar macrophage dysfunction and induction of alternative activation. Alcohol Clin Exp Res 36: 1952–1962.
    1. Das SK, Vasudevan DM (2007) Alcohol-induced oxidative stress. Life Sci 81: 177–187.
    1. Perregaux D, Gabel CA (1994) Interleukin-1 beta maturation and release in response to ATP and nigericin. evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem 269: 15195–15203.
    1. Martinon F, Burns K, Tschopp J (2002) The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10: 417–426.
    1. Gringhuis SI, Kaptein TM, Wevers BA, Theelen B, van der Vlist M, et al. (2012) Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1beta via a noncanonical caspase-8 inflammasome. Nat Immunol 13: 246–254.
    1. Sagulenko V, Thygesen SJ, Sester DP, Idris A, Cridland JA, et al. (2013) AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC. Cell Death Differ 20: 1149–1160.
    1. Masumoto J, Dowds TA, Schaner P, Chen FF, Ogura Y, et al. (2003) ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. Biochem Biophys Res Commun 303: 69–73.
    1. Arbabi S, Garcia I, Bauer GJ, Maier RV (1999) Alcohol (ethanol) inhibits IL-8 and TNF: Role of the p38 pathway. J Immunol 162: 7441–7445.
    1. Inokuchi T, Ka T, Yamamoto A, Moriwaki Y, Takahashi S, et al. (2008) Effects of ethanol on monosodium urate crystal-induced inflammation. Cytokine 42: 198–204.
    1. Oak S, Mandrekar P, Catalano D, Kodys K, Szabo G (2006) TLR2- and TLR4-mediated signals determine attenuation or augmentation of inflammation by acute alcohol in monocytes. J Immunol 176: 7628–7635.
    1. Jin M, Kumar A, Kumar S (2012) Ethanol-mediated regulation of cytochrome P450 2A6 expression in monocytes: Role of oxidative stress-mediated PKC/MEK/Nrf2 pathway. PLoS One 7: e35505.
    1. Broz P, von Moltke J, Jones JW, Vance RE, Monack DM (2010) Differential requirement for caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host Microbe 8: 471–483.
    1. Coll RC, O’Neill LA (2011) The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes. PLoS One 6: e29539.
    1. Stehlik C, Dorfleutner A (2007) COPs and POPs: Modulators of inflammasome activity. J Immunol 179: 7993–7998.
    1. Lopez-Castejon G, Luheshi NM, Compan V, High S, Whitehead RC, et al. (2013) Deubiquitinases regulate the activity of caspase-1 and interleukin-1beta secretion via assembly of the inflammasome. J Biol Chem 288: 2721–2733.
    1. Goral J, Karavitis J, Kovacs EJ (2008) Exposure-dependent effects of ethanol on the innate immune system. Alcohol 42: 237–247.
    1. Szabo G (1997) Alcohol’s contribution to compromised immunity. Alcohol Health Res World 21: 30–41.
    1. Barter PJ, Rye KA (2012) Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk. J Lipid Res 53: 1755–1766.

Source: PubMed

3
Subscribe